913 related articles for article (PubMed ID: 18707762)
41. Platinum complexes with 5-methyl-5(4-pyridyl)hydantoin and its 3-methyl derivatives: synthesis and cytotoxic activity - quantitative structure-activity relationships.
Bakalova A; Varbanov H; Buyukliev R; Momekov G; Ivanov D; Doytchinova I
Arch Pharm (Weinheim); 2011 Apr; 344(4):209-16. PubMed ID: 21469169
[TBL] [Abstract][Full Text] [Related]
42. Synthesis, structures and in vitro cytotoxicity of some platinum(II) complexes containing thiocarbamate esters.
Dolfen D; Schottler K; Valiahdi SM; Jakupec MA; Keppler BK; Tiekink ER; Mohr F
J Inorg Biochem; 2008 Dec; 102(12):2067-71. PubMed ID: 18707761
[TBL] [Abstract][Full Text] [Related]
43. Synthesis and in vitro cytotoxicity of cis-[Pt(NH(3))(NH(2)OH)Cl(2)].
Ye QS; Liu WP; Chen XZ; Yu Y; Chang QW; Hou SQ
Arch Pharm Res; 2010 Jun; 33(6):807-11. PubMed ID: 20607484
[TBL] [Abstract][Full Text] [Related]
44. New synthetic route to [bis-1,2-(aminomethyl)benzene]dichloroplatinum(II) complexes, screening for cytotoxic activity in cisplatin-sensitive and resistant human cancer cell lines, and reaction with glutathione.
Rinke K; Grünert R; Bednarski PJ
Pharmazie; 2001 Oct; 56(10):763-9. PubMed ID: 11683118
[TBL] [Abstract][Full Text] [Related]
45. Synthesis, characterization and antitumor activity of new type binuclear platinum(II) complexes.
Zhang J; Liu L; Gong Y; Zheng X; Yang M; Cui J; Shen S
Eur J Med Chem; 2009 May; 44(5):2322-7. PubMed ID: 18524422
[TBL] [Abstract][Full Text] [Related]
46. Cellular accumulation and cytotoxicity of macromolecular platinum complexes in cisplatin-resistant tumor cells.
Garmann D; Warnecke A; Kalayda GV; Kratz F; Jaehde U
J Control Release; 2008 Oct; 131(2):100-6. PubMed ID: 18691617
[TBL] [Abstract][Full Text] [Related]
47. Cytotoxic malonate platinum(II) complexes with 1,2,4-triazolo[1,5-a]pyrimidine derivatives: structural characterization and mechanism of the suppression of tumor cell growth.
Łakomska I; Hoffmann K; Wojtczak A; Sitkowski J; Maj E; Wietrzyk J
J Inorg Biochem; 2014 Dec; 141():188-197. PubMed ID: 25277461
[TBL] [Abstract][Full Text] [Related]
48. Cytotoxicity of 2,2':6',2' '-terpyridineplatinum(II) complexes against human ovarian carcinoma.
Lowe G; Droz AS; Vilaivan T; Weaver GW; Park JJ; Pratt JM; Tweedale L; Kelland LR
J Med Chem; 1999 Aug; 42(16):3167-74. PubMed ID: 10447962
[TBL] [Abstract][Full Text] [Related]
49. Synthesis and biological activity of binuclear platinum complexes containing two monofunctional cis-[Pt(NH3)2Cl]+ units bridged by 4,4'-dipyridyl selenides or sulfides.
Zhao G; Lin H; Zhu S; Sun H; Chen Y
Anticancer Drug Des; 1998 Oct; 13(7):769-77. PubMed ID: 9807161
[TBL] [Abstract][Full Text] [Related]
50. New platinum(II) complexes containing both an O,O'-chelated acetylacetonate ligand and a sulfur ligand in the platinum coordination sphere induce apoptosis in HeLa cervical carcinoma cells.
Muscella A; Calabriso N; De Pascali SA; Urso L; Ciccarese A; Fanizzi FP; Migoni D; Marsigliante S
Biochem Pharmacol; 2007 Jun; 74(1):28-40. PubMed ID: 17481588
[TBL] [Abstract][Full Text] [Related]
51. [Synthesis and antitumor activities of triazacyclodecane and its platinum (II) complex].
Zhou SS; Zhang QY; Qin K; Lu CH; Xie FX
Yao Xue Xue Bao; 2008 May; 43(5):490-4. PubMed ID: 18717336
[TBL] [Abstract][Full Text] [Related]
52. Quantitative measurement of the reduction of platinum(IV) complexes using X-ray absorption near-edge spectroscopy (XANES).
Hall MD; Daly HL; Zhang JZ; Zhang M; Alderden RA; Pursche D; Foran GJ; Hambley TW
Metallomics; 2012 Jun; 4(6):568-75. PubMed ID: 22569908
[TBL] [Abstract][Full Text] [Related]
53. Novel mechanisms of platinum drug resistance identified in cells selected for resistance to JM118 the active metabolite of satraplatin.
Samimi G; Kishimoto S; Manorek G; Breaux JK; Howell SB
Cancer Chemother Pharmacol; 2007 Feb; 59(3):301-12. PubMed ID: 16770583
[TBL] [Abstract][Full Text] [Related]
54. Synthesis, crystal structure, studies in solution and cytotoxicity of two new fluorescent platinum(II) compounds containing anthracene derivatives as a carrier ligand.
Marqués-Gallego P; den Dulk H; Brouwer J; Kooijman H; Spek AL; Roubeau O; Teat SJ; Reedijk J
Inorg Chem; 2008 Dec; 47(23):11171-9. PubMed ID: 18975941
[TBL] [Abstract][Full Text] [Related]
55. Platinum complexes can inhibit matrix metalloproteinase activity: platinum-diethyl[(methylsulfinyl)methyl]phosphonate complexes as inhibitors of matrix metalloproteinases 2, 3, 9, and 12.
Sasanelli R; Boccarelli A; Giordano D; Laforgia M; Arnesano F; Natile G; Cardellicchio C; Capozzi MA; Coluccia M
J Med Chem; 2007 Jul; 50(15):3434-41. PubMed ID: 17583333
[TBL] [Abstract][Full Text] [Related]
56. Preparation of antitumor oxaliplatin/cisplatin docking dinuclear platinum complex.
Noji M; Kizu R; Takeda Y; Akiyama N; Yoshizaki I; Eriguchi M; Kidani Y
Biomed Pharmacother; 2005 Jun; 59(5):224-9. PubMed ID: 15919175
[TBL] [Abstract][Full Text] [Related]
57. Synthesis and cytotoxicity of enantiomerically pure [1,2-diamino-1-(4-fluorophenyl)-3-methylbutane]platinum(II) complexes.
Dullin A; Dufrasne F; Gelbcke M; Gust R
ChemMedChem; 2006 Jun; 1(6):644-53. PubMed ID: 16892405
[TBL] [Abstract][Full Text] [Related]
58. Application of fluorescence microscopy for investigation of cellular distribution of dinuclear platinum anticancer drugs.
Kalayda GV; Zhang G; Abraham T; Tanke HJ; Reedijk J
J Med Chem; 2005 Aug; 48(16):5191-202. PubMed ID: 16078838
[TBL] [Abstract][Full Text] [Related]
59. Synthesis, characterization, and comparative in vitro cytotoxicity studies of platinum(II), palladium(II), and gold(III) methylsarcosinedithiocarbamate complexes.
Giovagnini L; Ronconi L; Aldinucci D; Lorenzon D; Sitran S; Fregona D
J Med Chem; 2005 Mar; 48(5):1588-95. PubMed ID: 15743200
[TBL] [Abstract][Full Text] [Related]
60. Asymmetrically substituted ethylenediamine platinum(II) complexes as antitumor agents: synthesis and structure-activity relationships.
Mailliet P; Segal-Bendirdjian E; Kozelka J; Barreau M; Baudoin B; Bissery MC; Gontier S; Laoui A; Lavelle F; Le Pecq JB
Anticancer Drug Des; 1995 Jan; 10(1):51-73. PubMed ID: 7695813
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]